Cibus, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Cibus, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than almost all Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $13 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 98% of Healthcare companies in United States.
- Growth Efficiency Ratio: Sales grew 2,218% in 3 years, but profit fell: $3,165 less profit per $100 of extra sales. Lower than 97% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-27.1×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 62% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$3,165Sales grew 2,218% in 3 years, but profit fell: $3,165 less profit per $100 of extra sales.
Lower than 97% of Healthcare companies in United States.
Asset Productivity Ratio
+2218% / +1261%In 3 years sales changed by +2218% while total assets changed by +1261%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-116.3×Operating cash was negative last year, while some debt falls due within a year.
Lower than 85% of Healthcare companies in United States.
Cash Cushion Ratio
−22%Debt, after subtracting cash, equals 22% of its market value (net debt).
Lower than 85% of Healthcare companies in United States.
Tangible Assets Ratio
13%Of every $100 the company owns, $13 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 98% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than almost all Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Cibus, Inc. made a loss over the last year. Cibus, Inc. owes $0.95 for every $1 it owns. Cibus, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCibus, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
7.23The share price is 7.23 times Cibus, Inc.'s book value per share, higher than 81% of Healthcare companies in United States.
Market cap
$107 MThe total market value of all of Cibus, Inc.'s shares at today's price (share price × number of shares), smaller than 65% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$15 MWhat Cibus, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.19Net worth divided by the number of shares. The share price of $1.40 is 7.2 times this, which is the P/B above.
Return on equity (ROE)
-223.2%Cibus, Inc. lost 223.2% of its shareholders' money over the last year, lower than 86% of Healthcare companies in United States.
Owes vs Owns
0.95×Cibus, Inc. owes $0.95 for every $1 it owns (high), higher than 85% of Healthcare companies in United States.
Dividend yield
NoneCibus, Inc. does not currently pay a dividend.
Revenue growth
-15%Revenue fell 15% in the year to Dec 2025, and grew 185% a year on average over 3 years.
Profit growth
LossCibus, Inc. made a loss in each of the last two years.
Profit margin
-3492.3%Cibus, Inc. lost $3492 for every $100 of revenue.
Interest cover
Not coveredCibus, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtCibus, Inc. had $23 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Cibus, Inc.: $107 M ÷ $15 M (30 Jun 2026) = 7.2.
What is Cibus, Inc.'s return on equity?
Cibus, Inc. lost 223.2% of its shareholders' money over the last year, lower than 86% of Healthcare companies in United States.
How much does Cibus, Inc. owe compared with what it owns?
Cibus, Inc. owes $0.95 for every $1 it owns (high), higher than 85% of Healthcare companies in United States.
Does Cibus, Inc. pay a dividend?
No. Cibus, Inc. does not currently pay a dividend.
Is Cibus, Inc.'s revenue growing?
Revenue fell 15% in the year to Dec 2025, and grew 185% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.